Developer docs
API playgroundTry for free, no card

Search company profiles

EW Biotech

Full company profile

uuid002doun

Namestring
EW Biotech
Legal namestring
EW Biotech GmbH
Websiteurl
ew-biotech.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

EW Biotech GmbH is a privately held German contract development and manufacturing organization (CDMO) headquartered in Leuna, Saxony-Anhalt, and a wholly-owned subsidiary of EW Nutrition GmbH (Visbek, Germany). Founded in 2016 with a technical team that has collaborated since 2012, the company operates an ISO 9001:2015-certified, multi-purpose biotech facility that delivers fermentation and downstream processing (DSP) services across the full scale ladder — from 1-5L bench reactors through 75-1,500L and 7,500-85,000L demonstration and commercial bioreactors. The plant is aseptic and aerobic, with fermentation capacity reaching an 85,000L (85m³) main fermentor and DSP covering separation (filter press, disc-stack), crossflow filtration (MF, UF, NF), SMB chromatography, ion exchange, crystallization, evaporation, spray drying, and packaging.

The core commercial offering is a vertically integrated scale-up service bundled with R&D, feasibility studies, technology transfer, and toll manufacturing, sold via direct enterprise engagement to biotech companies needing to bridge laboratory process to commercial production without building their own capital-intensive infrastructure. The Leuna bio-industrial park location provides an enabling network of long-term partners and ready access to raw materials, allowing EW Biotech to function as a single point of contact across the full program. Documented commercial-scale engagements include several tons of Genomatica's Brontide™ biobased butylene glycol (supporting awards including the 2017 ICIS Innovation Award and 2020 EPA Green Chemistry Award), 7 metric tons of Provivi's Fall Armyworm pheromone for the Pherogen™ product (covering ~400,000 hectares of corn), and over 6,000 kg of DMC Biotechnologies' L-alanine — each referencing side-by-side collaboration through planning, transfer, and execution.

EW Biotech monetizes primarily through project-based, quote-driven B2B contracts (no publicly disclosed pricing), with revenue streams spanning contract fermentation, DSP services, and contract/toll manufacturing. GTM is enterprise-direct with a single point of contact maintained throughout each customer's scale-up and production project. The company is privately held with no disclosed external funding, no public listing, and modest headcount (11-50 employees, ~30+ technologists); active hiring at the Leuna site, including a recently opened Technischer Leiter role, indicates ongoing capacity build.

Short descriptiontext

EW Biotech GmbH is a German biotech CDMO providing contract fermentation and downstream processing services from laboratory (1-5L) to commercial scale (85,000L), serving biotech, biobased chemical, and agricultural biotechnology customers via its ISO 9001:2015-certified facility in Leuna.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLeuna, Germany
HQ citystring
Leuna
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract fermentation services, biotech contract manufacturing, downstream processing services, bioprocess scale-up, biotech process development
Industry4 codes
PRIMARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
SECONDARYEUAAAIAN
Biorefinery Co-product Recovery, Purification & Separation (Downstream Processing Systems)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biotech Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Contract Fermentation Services
TypeProfessional Services
Description

Fermentation services from lab scale to commercial production scale using their multi-purpose biotech facility. Customers include biotech companies requiring scale-up support.

ew-biotech.com
2Downstream Processing (DSP)
TypeProfessional Services
Description

Separation, purification, and finishing services including filtration, chromatography, crystallization, drying and packaging for biotech products

ew-biotech.com
3Contract Manufacturing
TypeManaged Services
Description

Toll manufacturing and sample production services at commercial scale for biotech companies

ew-biotech.com
4R&D Services
TypeProfessional Services
Description

Research and development support, feasibility studies, and technical consulting from early-stage development through commercial production

ew-biotech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

EW Biotech provides bioprocess development, scale-up, and contract manufacturing services for the biotechnology industry from its ISO9001:2015-certified multi-purpose facility in Leuna, Germany. The company's core offering spans contract fermentation (bench scale 1-5L up to commercial-scale aseptic aerobic fermentation at 85,000L), full downstream processing (separation, filtration, chromatography, crystallization, drying, packaging), contract manufacturing and toll production, R&D and feasibility studies, and access to raw materials through an enabling network of long-term partners.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

EW Biotech is a biotech contract services provider offering an integrated suite of services to bring biotech products from concept to commercial scale. The company's core offering encompasses contract fermentation and downstream processing (DSP), research and development, biomanufacturing and packaging, and access to raw materials, all delivered through their enabling network at a biotech hub in Leuna, Germany. Services are structured across three operational scales: laboratory scale (bench scale fermentation 1-5L with full QA/QC and analytical capabilities including HPLC, GC, IC), pilot and demonstration scale (75-1,500L to 7,500-85,000L bioreactors with separation, filtration, chromatography, and drying capabilities), and commercial scale (aseptic aerobic fermentation up to 85,000L with purification, crystallization, drying, and packaging). The company operates as a single complete solution provider with no modular products or sub-brands.

Product and service4 records
1Contract Fermentation Services
CategoryBioprocess / Contract Fermentation
Description

Contract fermentation services executed at the ISO9001:2015-certified Leuna facility, spanning bench scale (1-5L), pilot and demonstration scale (75-85,000L bioreactors), and commercial-scale aseptic aerobic fermentation up to 85,000L. Designed for biotech companies needing outsourced fermentation capacity and scale-up support without building capital-intensive infrastructure themselves.

2Downstream Processing (DSP) Services
CategoryBioprocess / Downstream Processing
Description

Separation, purification, and finishing services covering filter press and disc-stack separation, crossflow filtration (MF, UF, NF), SMB chromatography, ion exchange, crystallization, evaporation, spray drying, and packaging. Targeted at biotech customers requiring full DSP capability as part of their scale-up and commercial production workflow.

3Contract Manufacturing (Toll Manufacturing)
CategoryContract Manufacturing / Toll Manufacturing
Description

Toll manufacturing and sample production services at commercial scale using the Leuna facility's 85,000L fermentor and full DSP stack. Targeted at biotech companies that need commercial-scale production capacity without owning dedicated infrastructure themselves, including production of biobased chemicals, agricultural pheromones, amino acids, and related bioproducts.

4Research & Development Services
CategoryBioprocess R&D / Technical Consulting
Description

Research and development, feasibility studies, and technical consulting services supporting biotech customers from early-stage development through commercial production, leveraging deep fermentation and DSP expertise and laboratory-scale (1-5L) capabilities with full QA/QC and HPLC/GC/IC analytics.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-05-13
Description

EW Biotech partnered with DMC to demonstrate full commercial scale fermentation (85m³) and downstream processing for L-alanine production. Successfully completed purification of over 6,000 kg of product meeting customer specifications. Project executed on schedule during COVID-19 pandemic. This validated DMC's Dynamic Metabolic Control technology for commercial viability.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-10
Description

EW Biotech and Provivi collaborated on pheromone biosynthesis scale-up at the EW Biotech facility in Leuna, Germany. Successfully scaled up to produce 7 metric tons of Fall Armyworm pheromone component. This scale-up enabled Provivi's Pherogen™ product launch for crop protection in Mexico and Kenya, protecting approximately 400,000 hectares of corn against Fall Armyworm.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

EW Biotech played a key role in Genomatica's commercialization of Brontide™ biobased butylene glycol. Produced several tons for market sampling, validated scale-up methodologies using 85,000L fermentor. EW Biotech contributed to Genomatica's success recognized by 2017 ICIS Innovation Award and 2020 EPA Green Chemistry Award.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the world's largest CDMOs with extensive microbial fermentation capacity and DSP infrastructure. Competes with EWB on commercial-scale fermentation projects but operates at vastly greater scale and breadth.

TypeBroad incumbent
Description

Global CDMO with large-scale microbial and mammalian fermentation capacity. Competes for industrial biotech scale-up contracts but at significantly greater scale and geographic reach.

TypeEmerging player
Description

Engineered enzymes and biocatalysis specialist with fermentation scale-up for protein and small-molecule products. Overlaps with EWB's customer base in biobased chemicals and specialty ingredients.

TypeDirect peer
Description

Finnish biotech CDMO offering process development, scale-up, and cGMP contract manufacturing for microbial and cell-based biologics. Highly comparable in size, service scope, and European positioning to EW Biotech.

TypeBroad incumbent
Description

Synthetic biology platform offering strain engineering and fermentation services. Competes for industrial biotech customers seeking scale-up, though differentiated by its platform/Codebase approach versus EWB's pure-service model.

TypeDirect peer
Description

Global CDMO providing microbial fermentation and downstream processing for biologics and biobased products. Direct competitor for industrial biotech scale-up and toll manufacturing customers.

TypeDirect peer
Description

European CRO/CDMO offering process development, scale-up, and contract manufacturing for biotech and pharma customers. Comparable mid-sized CDMO competing for similar industrial biotech programs.

8Capua BioServices
TypeDirect peer
Description

European-origin CDMO focused on microbial fermentation and DSP for industrial biotech customers. Comparable in scale, service scope, and target market to EW Biotech's contract manufacturing offering.

TypeRegional player
Description

German bioeconomy company with proprietary microbial strains and bioprocess development capabilities. Geographically and functionally adjacent to EW Biotech's biobased-chemicals and DSP focus.

TypeEmerging player
Description

Carbon-to-product fermentation company commercializing gas-fermentation at industrial scale. Comparable commercial-scale fermentation expertise, though focused on a distinct feedstock (gas) and product slate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EW Biotech

Biotech Contract Manufacturingew-biotech.com

EW Biotech GmbH is a German biotech CDMO providing contract fermentation and downstream processing services from laboratory (1-5L) to commercial scale (85,000L), serving biotech, biobased chemical, and agricultural biotechnology customers via its ISO 9001:2015-certified facility in Leuna.

What EW Biotech does

EW Biotech GmbH is a privately held German contract development and manufacturing organization (CDMO) headquartered in Leuna, Saxony-Anhalt, and a wholly-owned subsidiary of EW Nutrition GmbH (Visbek, Germany). Founded in 2016 with a technical team that has collaborated since 2012, the company operates an ISO 9001:2015-certified, multi-purpose biotech facility that delivers fermentation and downstream processing (DSP) services across the full scale ladder — from 1-5L bench reactors through 75-1,500L and 7,500-85,000L demonstration and commercial bioreactors. The plant is aseptic and aerobic, with fermentation capacity reaching an 85,000L (85m³) main fermentor and DSP covering separation (filter press, disc-stack), crossflow filtration (MF, UF, NF), SMB chromatography, ion exchange, crystallization, evaporation, spray drying, and packaging.

The core commercial offering is a vertically integrated scale-up service bundled with R&D, feasibility studies, technology transfer, and toll manufacturing, sold via direct enterprise engagement to biotech companies needing to bridge laboratory process to commercial production without building their own capital-intensive infrastructure. The Leuna bio-industrial park location provides an enabling network of long-term partners and ready access to raw materials, allowing EW Biotech to function as a single point of contact across the full program. Documented commercial-scale engagements include several tons of Genomatica's Brontide™ biobased butylene glycol (supporting awards including the 2017 ICIS Innovation Award and 2020 EPA Green Chemistry Award), 7 metric tons of Provivi's Fall Armyworm pheromone for the Pherogen™ product (covering ~400,000 hectares of corn), and over 6,000 kg of DMC Biotechnologies' L-alanine — each referencing side-by-side collaboration through planning, transfer, and execution.

EW Biotech monetizes primarily through project-based, quote-driven B2B contracts (no publicly disclosed pricing), with revenue streams spanning contract fermentation, DSP services, and contract/toll manufacturing. GTM is enterprise-direct with a single point of contact maintained throughout each customer's scale-up and production project. The company is privately held with no disclosed external funding, no public listing, and modest headcount (11-50 employees, ~30+ technologists); active hiring at the Leuna site, including a recently opened Technischer Leiter role, indicates ongoing capacity build.

EW Biotech firmographics

Firmographics
Name
EW Biotech
Legal name
EW Biotech GmbH
Website
https://ew-biotech.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
EW Biotech GmbH is a German biotech CDMO providing contract fermentation and downstream processing services from laboratory (1-5L) to commercial scale (85,000L), serving biotech, biobased chemical, and agricultural biotechnology customers via its ISO 9001:2015-certified facility in Leuna.
Ownership category
akta.pro rank

EW Biotech industry classification

Industry
Product category
Biotech Contract Manufacturing
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
SECONDARYEUAAAIAN
Biorefinery Co-product Recovery, Purification & Separation (Downstream Processing Systems)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHLAAAJAA
Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYAFABAEAM
Biological Formulation, Fermentation & Scale-Up Manufacturing
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)

Keywords

  • Contract fermentation services
  • Biotech contract manufacturing
  • Downstream processing services
  • Bioprocess scale-up
  • Biotech process development

Where EW Biotech is headquartered

Location

Headquarters

HQ city
Leuna
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

EW Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Contract Fermentation Services: Fermentation services from lab scale to commercial production scale using their multi-purpose biotech facility. Customers include biotech companies requiring scale-up support.
  2. Downstream Processing (DSP): Separation, purification, and finishing services including filtration, chromatography, crystallization, drying and packaging for biotech products
  3. Contract Manufacturing: Toll manufacturing and sample production services at commercial scale for biotech companies
  4. R&D Services: Research and development support, feasibility studies, and technical consulting from early-stage development through commercial production

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

EW Biotech product offering

Product offering

Core offering

EW Biotech provides bioprocess development, scale-up, and contract manufacturing services for the biotechnology industry from its ISO9001:2015-certified multi-purpose facility in Leuna, Germany. The company's core offering spans contract fermentation (bench scale 1-5L up to commercial-scale aseptic aerobic fermentation at 85,000L), full downstream processing (separation, filtration, chromatography, crystallization, drying, packaging), contract manufacturing and toll production, R&D and feasibility studies, and access to raw materials through an enabling network of long-term partners.

Product overview

EW Biotech is a biotech contract services provider offering an integrated suite of services to bring biotech products from concept to commercial scale. The company's core offering encompasses contract fermentation and downstream processing (DSP), research and development, biomanufacturing and packaging, and access to raw materials, all delivered through their enabling network at a biotech hub in Leuna, Germany. Services are structured across three operational scales: laboratory scale (bench scale fermentation 1-5L with full QA/QC and analytical capabilities including HPLC, GC, IC), pilot and demonstration scale (75-1,500L to 7,500-85,000L bioreactors with separation, filtration, chromatography, and drying capabilities), and commercial scale (aseptic aerobic fermentation up to 85,000L with purification, crystallization, drying, and packaging). The company operates as a single complete solution provider with no modular products or sub-brands.

Differentiator

Problem solved

Functional benefit

Products and services

  • Contract Fermentation Services Contract fermentation services executed at the ISO9001:2015-certified Leuna facility, spanning bench scale (1-5L), pilot and demonstration scale (75-85,000L bioreactors), and commercial-scale aseptic aerobic fermentation up to 85,000L. Designed for biotech companies needing outsourced fermentation capacity and scale-up support without building capital-intensive infrastructure themselves.
  • Downstream Processing (DSP) Services Separation, purification, and finishing services covering filter press and disc-stack separation, crossflow filtration (MF, UF, NF), SMB chromatography, ion exchange, crystallization, evaporation, spray drying, and packaging. Targeted at biotech customers requiring full DSP capability as part of their scale-up and commercial production workflow.
  • Contract Manufacturing (Toll Manufacturing) Toll manufacturing and sample production services at commercial scale using the Leuna facility's 85,000L fermentor and full DSP stack. Targeted at biotech companies that need commercial-scale production capacity without owning dedicated infrastructure themselves, including production of biobased chemicals, agricultural pheromones, amino acids, and related bioproducts.
  • Research & Development Services Research and development, feasibility studies, and technical consulting services supporting biotech customers from early-stage development through commercial production, leveraging deep fermentation and DSP expertise and laboratory-scale (1-5L) capabilities with full QA/QC and HPLC/GC/IC analytics.

Companies that use EW Biotech

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

EW Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

EW Biotech partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • DMC BiotechnologiescoreStrategic or Co-development Partner · 13 May 2021EW Biotech partnered with DMC to demonstrate full commercial scale fermentation (85m³) and downstream processing for L-alanine production. Successfully completed purification of over 6,000 kg of product meeting customer specifications. Project executed on schedule during COVID-19 pandemic. This validated DMC's Dynamic Metabolic Control technology for commercial viability.
  • ProvivicoreStrategic or Co-development Partner · 10 July 2020EW Biotech and Provivi collaborated on pheromone biosynthesis scale-up at the EW Biotech facility in Leuna, Germany. Successfully scaled up to produce 7 metric tons of Fall Armyworm pheromone component. This scale-up enabled Provivi's Pherogen™ product launch for crop protection in Mexico and Kenya, protecting approximately 400,000 hectares of corn against Fall Armyworm.
  • GenomaticacoreStrategic or Co-development PartnerEW Biotech played a key role in Genomatica's commercialization of Brontide™ biobased butylene glycol. Produced several tons for market sampling, validated scale-up methodologies using 85,000L fermentor. EW Biotech contributed to Genomatica's success recognized by 2017 ICIS Innovation Award and 2020 EPA Green Chemistry Award.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

EW Biotech competitors and assessment

Company assessment

Broad incumbents

  • Lonza: One of the world's largest CDMOs with extensive microbial fermentation capacity and DSP infrastructure. Competes with EWB on commercial-scale fermentation projects but operates at vastly greater scale and breadth.
  • WuXi Biologics: Global CDMO with large-scale microbial and mammalian fermentation capacity. Competes for industrial biotech scale-up contracts but at significantly greater scale and geographic reach.
  • Ginkgo Bioworks: Synthetic biology platform offering strain engineering and fermentation services. Competes for industrial biotech customers seeking scale-up, though differentiated by its platform/Codebase approach versus EWB's pure-service model.

Emerging players

  • Codexis: Engineered enzymes and biocatalysis specialist with fermentation scale-up for protein and small-molecule products. Overlaps with EWB's customer base in biobased chemicals and specialty ingredients.
  • LanzaTech: Carbon-to-product fermentation company commercializing gas-fermentation at industrial scale. Comparable commercial-scale fermentation expertise, though focused on a distinct feedstock (gas) and product slate.

Direct peers

  • Biovian: Finnish biotech CDMO offering process development, scale-up, and cGMP contract manufacturing for microbial and cell-based biologics. Highly comparable in size, service scope, and European positioning to EW Biotech.
  • AGC Biologics: Global CDMO providing microbial fermentation and downstream processing for biologics and biobased products. Direct competitor for industrial biotech scale-up and toll manufacturing customers.
  • Selvita: European CRO/CDMO offering process development, scale-up, and contract manufacturing for biotech and pharma customers. Comparable mid-sized CDMO competing for similar industrial biotech programs.
  • Capua BioServices: European-origin CDMO focused on microbial fermentation and DSP for industrial biotech customers. Comparable in scale, service scope, and target market to EW Biotech's contract manufacturing offering.

Regional players

  • BRAIN Biotech: German bioeconomy company with proprietary microbial strains and bioprocess development capabilities. Geographically and functionally adjacent to EW Biotech's biobased-chemicals and DSP focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

EW Biotech social profiles

Digital presence

EW Biotech compliance and trust

Trust signal

Compliance1 record

EW Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EW Biotech leadership team

Management profile

Number of profiles

Profiles7 records

EW Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EW Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EW Biotech

What does EW Biotech do?

EW Biotech provides bioprocess development, scale-up, and contract manufacturing services for the biotechnology industry from its ISO9001:2015-certified multi-purpose facility in Leuna, Germany. The company's core offering spans contract fermentation (bench scale 1-5L up to commercial-scale aseptic aerobic fermentation at 85,000L), full downstream processing (separation, filtration, chromatography, crystallization, drying, packaging), contract manufacturing and toll production, R&D and feasibility studies, and access to raw materials through an enabling network of long-term partners.

Is EW Biotech a public or private company?

EW Biotech is a private company. It is classified as corporate owned and is currently operating.

When was EW Biotech founded?

EW Biotech was founded in 2016. It employs 11 to 50 people.

Where is EW Biotech based?

EW Biotech is headquartered in Leuna, Germany, in the Europe region.

How does EW Biotech make money?

Four revenue lines are on record. Contract Fermentation Services are the primary driver. The others are downstream Processing (DSP), contract Manufacturing and R&D Services.

Who are EW Biotech's main competitors?

Broad incumbents on record are Lonza, WuXi Biologics and Ginkgo Bioworks. Emerging players are Codexis and LanzaTech. Direct peers are Biovian, AGC Biologics, Selvita and Capua BioServices. BRAIN Biotech is listed as a regional player.

Does EW Biotech have an API?

No public API is recorded for EW Biotech.

What industry is EW Biotech in?

EW Biotech's product category is Biotech Contract Manufacturing. Its primary akta.pro industry code is HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream), with a secondary code of EUAAAIAN, Biorefinery Co-product Recovery, Purification & Separation (Downstream Processing Systems). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales